ICMDNR · Registering as Listener

International Conference on Movement Disorders and Neurological Research

17th Apr – 18th Apr 2027 Antwerp, Belgium Standard / Physical Participation
Listener Registration From
$—
$— in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

For Support Please Contact

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply
VISA MC AMEX UPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICMDNR
ModeStandard / Physical
ParticipationListener
Registration fee$—
Bank charges (5.8%)$—
Discount-$0.00
Total payable $—

Includes all bank processing charges — the amount above is exactly what will be charged. View charge breakdown

Need help?

Contact our registration team:

Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
Conference Session Tracks
SDG Wheel

SDG-Aligned Research Themes

International Conference on Movement Disorders and Neurological Research conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure SDG 10 - Reduced Inequalities

This track will explore the latest findings in the pathophysiology and treatment of Parkinson's disease. Researchers are encouraged to present innovative therapeutic approaches and novel biomarkers.

This session will focus on the application of advanced neuroimaging techniques in understanding movement disorders. Presentations will highlight how imaging can inform diagnosis and treatment strategies.

This track will delve into the interplay between genetic predispositions and environmental influences in the development of movement disorders. Studies addressing gene-environment interactions are particularly welcome.

This session will showcase recent clinical trials aimed at developing new therapies for movement disorders. Participants are encouraged to discuss challenges and successes in trial design and implementation.

This track will examine the neurophysiological mechanisms underlying various movement disorders. Presentations should focus on electrophysiological studies and their implications for treatment.

This session will address the cognitive aspects associated with movement disorders, particularly in Parkinson's disease. Research on the assessment and management of cognitive decline will be highlighted.

This track will emphasize the importance of patient-centered care in the management of movement disorders. Discussions will focus on shared decision-making and the role of patient-reported outcomes.

This session will explore novel rehabilitation strategies for individuals with movement disorders. Presentations may include technology-assisted therapies and multidisciplinary approaches.

This track will investigate the role of neuroinflammation in the pathogenesis of movement disorders. Research highlighting potential anti-inflammatory treatments will be particularly relevant.

This session will focus on the unique challenges associated with diagnosing and treating movement disorders in pediatric populations. Innovative strategies and case studies will be presented.

This track will address the ethical implications of conducting research in the field of neurology, particularly concerning vulnerable populations. Discussions will include informed consent and the use of placebos.

COPYRIGHT © 2026 International Conference on Movement Disorders and Neurological Research. ALL RIGHTS RESERVED